Effect of dapagliflozin as an add-on therapy to insulin on the glycemic variability in subjects with type 2 diabetes mellitus (DIVE): A multicenter, placebo-controlled, double-blind, randomized study - Lee, S H; Min, K W; Lee, B W (Diabetes Metab J, 2021)
et al.